Search research articles
Contact Us
Filters
Showing results (11-20 of 167) with videos related to
Page
of 17
Sort By:
The Lancet. Respiratory Medicine
|
July 11, 2022
Monoclonals for patients hospitalised with COVID-19
Jason M Pogue, Erin K McCreary
Pharmacotherapy
|
January 30, 2015
Polymyxins in 2015: it's like déjà vu all over again
Jason M Pogue, John C Rotschafer
The Lancet. Infectious Diseases
|
January 20, 2024
Is it time to join the oral antibiotics bandwagon?
Julie Ann Justo, Jason M Pogue
Open Forum Infectious Diseases
|
January 19, 2024
Nut Cracked? Does the ACORN Trial End the Debate Surrounding Vancomycin and Piperacillin-Tazobactam Combination Therapy and Increased Risk for Acute Kidney Injury?
Jason M Pogue, Samuel L Aitken
Open Forum Infectious Diseases
|
June 24, 2026
What's Behind DOOR Number 2? Recent Applications From Post-Hoc Analyses of Infectious Diseases Randomized Clinical Trials
Jason M Pogue, Ryan K Shields
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 19, 2017
Reply to Manian
Jason M Pogue, Bhagyashri Navalkele, Keith S Kaye
Journal of Burn Care & Research : Official Publication of the American Burn Association
|
August 29, 2014
Pharmacokinetics and pharmacodynamics of antibacterial and antifungal agents in adult patients with thermal injury: a review of current literature
Jessica K Ortwine, Jason M Pogue, Janie Faris
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 9, 2019
Analysis of Pooled Phase III Efficacy Data for Delafloxacin in Acute Bacterial Skin and Skin Structure Infections
Philip A Giordano, Jason M Pogue, Sue Cammarata
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 30, 2015
Editorial commentary: Polymyxin-resistant Acinetobacter baumannii: urgent action needed
Jason M Pogue, David A Cohen, Dror Marchaim
Infectious Diseases and Therapy
|
February 20, 2020
Cefiderocol: A Novel Agent for the Management of Multidrug-Resistant Gram-Negative Organisms
Janet Y Wu, Pavithra Srinivas, Jason M Pogue
Page
of 17
Search research articles
Search
Showing results (11-20 of 167) with videos related to
Sort By:
Page
of 17
The Lancet. Respiratory Medicine
|
July 11, 2022
Monoclonals for patients hospitalised with COVID-19
Jason M Pogue, Erin K McCreary
Pharmacotherapy
|
January 30, 2015
Polymyxins in 2015: it's like déjà vu all over again
Jason M Pogue, John C Rotschafer
The Lancet. Infectious Diseases
|
January 20, 2024
Is it time to join the oral antibiotics bandwagon?
Julie Ann Justo, Jason M Pogue
Open Forum Infectious Diseases
|
January 19, 2024
Nut Cracked? Does the ACORN Trial End the Debate Surrounding Vancomycin and Piperacillin-Tazobactam Combination Therapy and Increased Risk for Acute Kidney Injury?
Jason M Pogue, Samuel L Aitken
Open Forum Infectious Diseases
|
June 24, 2026
What's Behind DOOR Number 2? Recent Applications From Post-Hoc Analyses of Infectious Diseases Randomized Clinical Trials
Jason M Pogue, Ryan K Shields
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 19, 2017
Reply to Manian
Jason M Pogue, Bhagyashri Navalkele, Keith S Kaye
Journal of Burn Care & Research : Official Publication of the American Burn Association
|
August 29, 2014
Pharmacokinetics and pharmacodynamics of antibacterial and antifungal agents in adult patients with thermal injury: a review of current literature
Jessica K Ortwine, Jason M Pogue, Janie Faris
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 9, 2019
Analysis of Pooled Phase III Efficacy Data for Delafloxacin in Acute Bacterial Skin and Skin Structure Infections
Philip A Giordano, Jason M Pogue, Sue Cammarata
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 30, 2015
Editorial commentary: Polymyxin-resistant Acinetobacter baumannii: urgent action needed
Jason M Pogue, David A Cohen, Dror Marchaim
Infectious Diseases and Therapy
|
February 20, 2020
Cefiderocol: A Novel Agent for the Management of Multidrug-Resistant Gram-Negative Organisms
Janet Y Wu, Pavithra Srinivas, Jason M Pogue
Page
of 17